SavedAdd your journal

Journals / MN Oftalmoloji / 2020 / Cilt: 27 - Sayı: 2

Presumed Inflammatory Choroidal Neovascular Membrane in a Focus Different from an Old Toxoplasma Retinochoroiditis Focus

Geçirilmiş Toksoplazma Retinokoroidit Odağından Bağımsız Bir Odakta Gelişen Olası Enflamatuvar Koroidal Neovasküler Membran

Emine TEMEL
Emin ÖZMERT
FATİME NİLÜFER YALÇINDAĞ
Pages
112–115
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this study is to present the possible inflammatory choroidal neovascular membrane developing in a focus different from an old toxoplasma retinochoroiditis focus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Choroidal neovascular membrane may develop in the macular region as a late complication of toxoplasmic retinocoroiditis.
📊
Key Findings & Data:There is no standard treatment protocol for these cases.
💡
Conclusion & Impact:The aim of this study is to present the possible inflammatory choroidal neovascular membrane developing in a focus different from an old toxoplasma retinochoroiditis focus.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Choroidal neovascular membrane may develop in the macular region as a late complication of toxoplasmic retinocoroiditis. There is no standard treatment protocol for these cases. Anti-inflammatory treatment for the underlying inflammatory pathology, intravitreal anti-vascular endothelial growth factor injection and photodynamic therapy can be used for these cases. The aim of this study is to present the possible inflammatory choroidal neovascular membrane developing in a focus different from an old toxoplasma retinochoroiditis focus.

Özet

Toksoplazma retinokoroiditinin geç bir komplikasyonu olarak maküler bölgede koroidal neovasküler membran gelişebilmektedir. Bu olgular için günümüzde standart bir tedavi protokolü yoktur. Altta yatan enflamatuvar patolojiyi hedef alan antienflamatuvar tedavi, intravitreal anti-vasküler endotelyal büyüme faktörü enjeksiyonu ve fotodinamik tedavi kullanılabilmektedir. Bu çalışmanın amacı, geçirilmiş toksoplazma retinokoroidit odağından bağımsız bir odakta gelişen olası enflamatuvar koroidal neovasküler membranı sunmak ve tedavisini tartışmaktır.

🔖

Cite This Article

TEMEL, E., ÖZMERT, E., YALÇINDAĞ, F. N. (2020). Presumed Inflammatory Choroidal Neovascular Membrane in a Focus Different from an Old Toxoplasma Retinochoroiditis Focus. MN Oftalmoloji, Cilt: 27 - Sayı: 2, 112–115. https://ajindex.com/articles/295352

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Atmaca LS. Simsek T. Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48(4):386-91
  2. Adan A. Mateo C. Wolley-Dod C. Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis. Am J Ophthalmol. 2003;135(3):386-7
  3. Rosenfeld PJ. Saperstein DA. Bressler NM. et al. Verteporfin in Ocular Histoplasmosis Study Group. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled open-label 2- year study. Ophthalmology. 2004;111(9):1725-33
  4. Ben Yahia S. Herbort CP. Jenzeri S. et al. Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis. Int Ophthalmol. 2008;28(4):311-6
  5. Oliveira LB. Reis PA. Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis. Graefes Arch Clin Exp Ophthalmol. 2004;242(12):1028-30
  6. Gür Güngör S. Akkoyun İ. Şingar E. Yılmaz G. Toksoplazma koryoretinitine ikincil koroidal neovasküler membran olgusunda int ravitreal bevacizumab enjeksiyon tedavisi. Turk Oftalmol Gaz. 2014;44(2):236-38
  7. Hedge S. Relhan N. Pathengay A. et al. Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis. J Ophthalmic Inflamm Infect. 2015;5:22
  8. Rishi P. Venkataraman A. Rishi E. Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol. 2011;59(1):62-4.